Digital innovation continues to rapidly transform healthcare while, at the same time, raising several policy challenges, including privacy, security, data sharing and interoperability, transparency, safety and effectiveness, and...
Read more
Rare diseases are considered rare because they affect relatively tiny numbers of people: up to 200,000 in the U.S., for example, and less than one in 2,000 in...
Read more
No look ahead at women’s health issues in 2022 would be complete without a discussion of thecontinuing impact of the COVID-19 pandemic. COVID-19 death rates are significantly higher...
Read more
Historically, the World Health Organization (WHO) has led extraordinary efforts to eliminate, and even eradicate, highly communicable diseases such as malaria and smallpox in low- and middle-income countries....
Read more
Antimicrobial resistance (AMR), which is making a growing range of antibiotics ineffective, is anincreasingly critical problem. Driven largely by the improper use of antibiotics, AMR causes more than...
Read more
It’s fair to say that the current state of health financing is mixed. On the one hand, outside of pandemic-related funding, public financing hasn’t kept pace with the...
Read more
Nothing in recent years has focused the world’s attention on the development, use, and efficacy of vaccines more than COVID-19. Through efficient public-private partnerships, global R&D platforms generated...
Read more
